Podiatry Today: PAD Awareness Month And The Case For Limb Preservation
September 1, 2014

Unlike October, which is abundant with the color pink and matching ribbons symbolizing Breast Cancer Awareness Month wherever we turn, we have no such ribbon for Peripheral Artery Disease (PAD) Awareness Month. In my travels over the past few years, I have noted several instances that illustrate a lack of PAD awareness and understanding among… more

 

Low Income and Lower Education Levels Associated with Peripheral Vascular Disease in U.S. Adults
August 19, 2014

Recent findings published by the American Heart Association reveal that U.S. adults with lower socioeconomic status are at higher risk for developing Peripheral Vascular Disease (PVD) – highlighting the need for education and advocacy among at-risk populations. According to the study published in Circulation: Cardiovascular Quality and Outcomes, individuals with low income and lower education… more

 

JAMA Surgery: Aortic Stents Safer for Aneurysm Repairs
August 19, 2014

Post-operative complications and mortality rates were significantly lower for patients with abdominal aortic aneurysms repaired via endovascular stent grafts, according to new research published in the Journal of the American Medical Association (JAMA). Although anecdotal evidence and randomized clinical trials have long supported that endovascular repair is safer than more invasive, open surgeries, the published… more

 

Dark Chocolate Improves Walking Autonomy in Patients With Peripheral Artery Disease
August 19, 2014

Patients with Peripheral Artery Disease (PAD) might find relief from dark chocolate, according to research published in the Journal of the American Heart Association. PAD – a common circulatory problem where narrowed arteries reduce blood flow to the limbs – often results in pain when blood flow cannot keep up with the body’s demands, particularly… more

 

Extended Release Niacin-Laropiprant Proves More Harmful than Helpful in High-Risk Patients
August 19, 2014

Patients receiving statin therapy for high cholesterol who additionally received a combination of extended-release niacin and laropiprant, saw reductions in their HDL, but saw no difference in the rate of major vascular events. The test group, in fact, experienced a higher rate of adverse events and complications when compared to patients taking a placebo. The… more

 

Scientists Discover Genetic Switch that Can Prevent Peripheral Vascular Disease in Mice
August 19, 2014

Scientists at the University of Texas Health Science Center at Houston have tested a non-surgical treatment in mice that could improve Peripheral Vascular Disease (PVD) by increasing blood circulation in the extremities. Researchers were able to identify a genetic “switch” that suppresses blood vessel development, and then turn off that switch in mice – allowing… more

 

Endovascular Today: The Outpatient Endovascular and Interventional Society
January 1, 2014

Although outpatient or office-based interventional suites have been operational for many years, there has been a marked proliferation of these sites in multiple states in the past 3 years. It is estimated that nearly 350 to 400 office-based labs exist in the United States to date, and that number is growing rapidly. Office-based labs, also… more

 

Preventive Aspects in Peripheral Artery Disease
June 2, 2012

Abstract The prevalence of peripheral artery disease is steadily increasing and is associated with significant morbidity, including a significant percentage of amputations. Peripheral artery disease often goes undiagnosed, making its prevention increasingly important. Patients with peripheral arterial disease are at increased risk of adverse cardiovascular outcomes which makes prevention even more important. Several risk factors… more